The use of prostatilen in treating patients with chronic prostatitis
Tkachuk VN, Gorbachev AG, Khavinson VKh · 1991 · Urol Nefrol (Mosk) (6):40-43. PMID 1823682
What does this source report?
An early tissue-derived prostate-preparation report describes symptom, laboratory and urodynamic changes after treatment, with follow-up at 4–6 months.
- Population and setting
- 307 men with chronic prostatitis
- Evidence type
- Uncontrolled human report
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- The abstract does not establish a randomized concurrent control.
- Reported tolerability cannot establish long-term safety; findings do not apply to Prostamax.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.
Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.
Cite and trace this record
Original source: Tkachuk VN, Gorbachev AG, Khavinson VKh. The use of prostatilen in treating patients with chronic prostatitis Urol Nefrol (Mosk) (6):40-43. PMID 1823682 1991.
Molekul research summary: https://molekul.io/research/bio-1823682. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry